• <em>In silico</em> Prediction and Evaluation of Human Parainfluenza Virus-3 CD4⁺ T Cell Epitopes
• A Comparative Study of the Effects of Al(OH)(3) and AlPO(4) Adjuvants on the Production of Neutralizing Antibodies (NAbs) against Bovine parainfluenza Virus Type 3 (BPIV3) in Guinea Pigs
• A fatal case of neonatal viral sepsis caused by human parainfluenza virus type 3
• A multicentre study on the incidence of respiratory viruses in children with community-acquired pneumonia requiring hospitalization in the setting of the zero-COVID policy in China
• A single dose intranasal combination panebolavirus vaccine
• A Single-Dose Intranasal Combination Panebolavirus Vaccine
• ADAR1p110 promotes Enterovirus D68 replication through its deaminase domain and inhibition of PKR pathway
• Analysis of gene expression dynamics and differential expression in viral infections using generalized linear models and quasi-likelihood methods
• Analysis of relationship between distribution of pathogenic microorganisms in olfactory cleft and olfactory disorders among patients with upper respiratory inflammation during the prevention and control of COVID-19
• Application of MRT-qPCR for pathogen detection of lower respiratory tract infection
• Bovine parainfluenza type 3 virus induces incomplete autophagy to promote viral replication by activated beclin1 in vitro
• Bovine parainfluenza virus type 3 infections induce ER stress-mediated autophagy to facilitate virus replication
• Bovine Parainfluenza-3 Virus Detection Methods and Prevalence in Cattle: A Systematic Review and Meta-Analysis
• Bta-miR-677 contribute to interferon pathway affecting the proliferation of caprine parainfluenza virus type 3
• Changing respiratory pathogens infection patterns after COVID-19 pandemic in Shanghai, China
• Characterization of viral pathogens associated with symptomatic upper respiratory tract infection in adults during a low COVID-19 transmission period
• Clinical impact of human parainfluenza virus infections before and during the COVID-19 pandemic in Southern China
• Comparative efficacy of modified-live and inactivated vaccines in boosting responses to bovine respiratory syncytial virus, bovine parainfluenza virus Type 3, and bovine coronavirus following neonatal mucosal priming of beef calves
• Construction and characterization of a reverse genetics system of bovine parainfluenza virus type 3c as a tool for rapid screening of antivirals <em>in vitro</em>
• Construction of an IFNAR1 knockout MDBK cell line using CRISPR/Cas9 and its effect on bovine virus replication
• Critical role of G3BP1 in bovine parainfluenza virus type 3 (BPIV3)-inhibition of stress granules formation and viral replication
• Cross-sectional study of primary antimicrobial treatment and vaccination coverage in outbreaks of bovine respiratory disease on dairy and beef farms in northern Belgium
• Development and evaluation of a monoclonal antibody-based blocking ELISA to detect antibodies against the E2 protein of bovine viral diarrhea virus-1
• Development and validation of a pentaplex assay for the identification of antibodies against common viral diseases in cattle
• Economic burden of respiratory syncytial and parainfluenza viruses in children of upper-middle-income countries: a systematic review
• Effects of Coronavirus Disease 2019 on Prevalence of Acute Respiratory Viruses: Changes during the Pandemic
• Epicatechin analogues may hinder human parainfluenza virus infection by inhibition of hemagglutinin neuraminidase protein and prevention of cellular entry
• Epidemiology of Human Parainfluenza Virus Type 3 and Respiratory Syncytial Virus Infections in the Time of Coronavirus Disease 2019: Findings From a Household Cohort in Maryland
• Epidermal growth factor receptor (EGFR) promotes uptake of bovine parainfluenza virus type 3 into MDBK cells
• Evaluation of a Live-Attenuated Human Parainfluenza Virus Type 2 Vaccine in Adults and Children
• Evaluation of the immunogenicity and protective efficacy of an inactivated vaccine candidate for sheep infected with ovine parainfluenza virus type 3
• First Isolation and Characteristics of Bovine Parainfluenza Virus Type 3 from Yaks
• Functional and structural basis of human parainfluenza virus type 3 neutralization with human monoclonal antibodies
• Generation of a photocontrollable recombinant bovine parainfluenza virus type 3
• Genetic Analysis of HPIV3 That Emerged during the SARS-CoV-2 Pandemic in Gwangju, South Korea
• Genetic analysis of human parainfluenza type 2 virus in Riyadh, Saudi Arabia
• Genetic Comparison of Human Parainfluenza Virus Type 3 Detected in Respiratory Samples from Patients with Encephalopathy and Airway Inflammation in Aichi Prefecture, Japan
• High incidence of the virus among respiratory pathogens in children with lower respiratory tract infection in northwestern China
• Human metapneumovirus in hospitalized children with acute respiratory tract infections in Beijing, China
• Human parainfluenza 2 &amp;amp; 4: Clinical and genetic epidemiology in the UK, 2013-2017, reveals distinct disease features and co-circulating genomic subtypes
• Human parainfluenza 3 and respiratory syncytial viruses detected in pangolins
• Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters
• Hylin-a1: A Pan-Inhibitor against Emerging and Re-Emerging Respiratory Viruses
• Immunogenicity and protective efficacy of a recombinant adenovirus containing the fusion protein of bovine parainfluenza virus type 3 genotype C in mice
• Immunoinformatics-aided rational design of multiepitope-based peptide vaccine (MEBV) targeting human parainfluenza virus 3 (HPIV-3) stable proteins
• Impact of the COVID-19 pandemic on the prevalence of respiratory viral pathogens in patients with acute respiratory infection in Shanghai, China
• In silico Prediction and Evaluation of Human Parainfluenza Virus-3 CD4(+) T Cell Epitopes
• Incidence of Respiratory Pathogens in Naval Special Warfare Sea, Air, and Land Team Candidates With Swimming-Induced Pulmonary Edema
• Inefficient antiviral response in reconstituted small-airway epithelium from chronic obstructive pulmonary disease patients following human parainfluenza virus type 3 infection
• Influence of COVID-19 pandemic on the virus spectrum in children with respiratory infection in Xuzhou, China: a long-term active surveillance study from 2015 to 2021
• Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques
• Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys
• Isolation and Genomic Characterization of a Chinese Genotype C Bovine Parainfluenza Virus Type 3 from Cattle and Its Pathogenicity in C57BL/6 Mice
• Isolation and Molecular Characterisation of Respirovirus 3 in Wild Boar
• Isolation, Identification, and Genetic Phylogenetic Analysis of Two Different Genotypes of Bovine Parainfluenza 3 Virus in China
• Kinetic analysis of paramyxovirus-sialoglycan receptor interactions reveals virion motility
• Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters
• Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters
• Liver Enzyme Elevation Related to Human Parainfluenza Virus Type 3 Infection
• Molecular epidemiology of a Parainfluenza Type 3 virus outbreak: Informing infection control measures on adult hematology wards
• Molecular Epidemiology of Human Parainfluenza Virus Type 3 in Children With Acute Respiratory Tract Infection in Hangzhou
• Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants
• Nosocomial human parainfluenza virus type 3 outbreak in immunocompromised patients, and possible lessons from the SARS-CoV-2 pandemic
• Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease
• Parainfluenza and corona viruses in a fallow deer (<em>Dama dama</em>) with fatal respiratory disease
• Parainfluenza virus 5 is a next-generation vaccine vector for human infectious pathogens
• Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding
• Pathogenic infection characteristics and risk factors for bovine respiratory disease complex based on the detection of lung pathogens in dead cattle in Northeast China
• Phylogenetic analysis of human parainfluenza type 3 virus strains responsible for the outbreak during the COVID-19 pandemic in Seoul, South Korea
• Phylogenetic lineage dynamics of global parainfluenza virus type 3 post-COVID-19 pandemic
• Piercing of the Human Parainfluenza Virus by Nanostructured Surfaces
• Plastic Bronchitis of Human Bocavirus 1 Detected by Comprehensive Polymerase Chain Reaction of Mucus Casts
• Potent HPIV3-neutralizing IGHV5-51 Antibodies Identified from Multiple Individuals Show L Chain and CDRH3 Promiscuity
• Prevalence and Molecular Characterization of Bovine Parainfluenza Virus Type 3 in Cattle Herds in China
• Prevalence of respiratory viruses among hospitalized children with lower respiratory tract infections during the COVID-19 pandemic in Wuhan, China
• Prevalence, Molecular Characteristics and Virulence Identification of Bovine Parainfluenza Virus Type 3 in China
• Quantitative proteomic analysis shows involvement of the p38 MAPK pathway in bovine parainfluenza virus type 3 replication
• Recent increase in the detection of human parainfluenza virus during the coronavirus disease-2019 pandemic in the Republic of Korea
• Reemergence of Parainfluenza Virus Type 3 and Respiratory Syncytial Virus Infections During the COVID-19 Pandemic
• Research Progress on Emerging Viral Pathogens of Small Ruminants in China during the Last Decade
• Safety and Immunogenicity of an mRNA-Based hMPV/PIV3 Combination Vaccine in Seropositive Children
• Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults
• Seasonal epidemiological and clinical characteristics of pediatric patients with human parainfluenza virus infection by serotype: a retrospective study
• Serodiagnosis and Risk Factors Associated with Infectious Agents of Reproductive Diseases in Bovines of Chiquinquirá, District of Boyacá (Colombia)
• Shift in Clinical Epidemiology of Human Parainfluenza Virus Type 3 and Respiratory Syncytial Virus B Infections in Korean Children Before and During the COVID-19 Pandemic: A Multicenter Retrospective Study
• Structural basis for dimerization of a paramyxovirus polymerase complex
• Subnanometer structure of an enveloped virus fusion complex on viral surface reveals new entry mechanisms
• The Epidemiology of Pathogens in Community-Acquired Pneumonia Among Children in Southwest China Before, During and After COVID-19 Non-pharmaceutical Interventions: A Cross-Sectional Study
• The Prevalence, Coexistence, and Correlations between Seven Pathogens Detected by a PCR Method from South-Western Poland Dairy Cattle Suffering from Bovine Respiratory Disease
• The trehalose glycolipid C18Brar promotes antibody and T-cell immune responses to Mannheimia haemolytica and Mycoplasma ovipneumoniae whole cell antigens in sheep
• Total and pathogen-specific serum Immunoglobulin G concentrations in neonatal beef calves, Part 1: Risk factors
• Total and pathogen-specific serum Immunoglobulin G concentrations in neonatal beef calves, Part 2: Associations with health and growth
• Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein
• Unraveling dynamics of paramyxovirus-receptor interactions using nanoparticles displaying hemagglutinin-neuraminidase
• Use of a multiplex polymerase chain reaction assay for the early detection of an outbreak of human parainfluenza virus type 3 infection in a nursery school during the COVID-19 pandemic
• Vaccination protocols in Québec dairy herds
• Vimentin inhibits alpha-tubulin acetylation via enhancing alpha-TAT1 degradation to suppress the replication of human parainfluenza virus type 3
• Vimentin inhibits α-tubulin acetylation via enhancing α-TAT1 degradation to suppress the replication of human parainfluenza virus type 3
• Viral detection from negative mumps cases with respiratory symptoms in Gwangju, South Korea in 2021
• Viral loads of parainfluenza virus type 3 and severity of respiratory diseases in children